Please Wait.....
Report
South & Central America Stem Cell Therapy Market Forecast to 2028 - Regional Analysis - by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
Market Report I 2023-11-16 I 120 Pages I The Insight Partners
The South & Central America stem cell therapy is expected to grow from US$ 75.16 million in 2022 to US$ 139.30 million by 2028. It is estimated to grow at a CAGR of 10.8% from 2022 to 2028.
Use of Induced Pluripotent Stem Cells in Regenerative Medicines Drives South & Central America Stem Cell Therapy Market
Per the Frontiers Media S.A. 2023 report, progress in the field of induced pluripotent stem cells (iPSCs) has opened a new gateway for research in therapeutics. iPSCs are mainly intended for research and clinical studies such as disease modeling, regenerative medicine, and drug discovery/drug cytotoxicity studies. For example, iPSCs can be used to convert differentiated somatic cells to multipotent stem cells to generate different cell types of adult tissues. Thus, iPSCs have shown promising results in regenerative medicine, particularly for replacing diseased or injured cells. iPSCs are widely used to regenerate tissue-specific cells for transplantation in patients for treating injuries and degenerative diseases. Studies such as drug discovery involving screening of small molecules and toxicity testing for safety assessment have been successfully disclosed positive iPSCs-based results. The aforementioned factors are expected to offer lucrative growth opportunities to companies in the South & Central America stem cell therapy market in the coming years.
South & Central America Stem Cell Therapy Overview
The government and healthcare authorities in Brazil are implementing constructive strategies to increase the awareness and exposure of stem cell therapies in the countries. For example, providing international exposure, the authorities are focusing on conducting clinical trials in the country. For instance, according to clinicaltrials.gov, in 2016, around 27 stem cell studies were being conducted in the country, which accounted for an estimated 1.7% of all the stem cell studies across the globe. Also, the country allotted around US$ 5.0 Mn for stem cell research at the starting beginning of the entry in the stem cell domain. Increasing awareness in the country is fueling the growth of innovations and discoveries in the stem cell market. For instance, in 2017, R-Crio, a Brazil-based startup, discovered a way to produce around 7 million stem cells from a single baby tooth. These factors are likely to drive the growth of the Brazil stem cell therapy market during the forecast period.
South & Central America Stem Cell Therapy Revenue and Forecast to 2028 (US$ Million)
South & Central America Stem Cell Therapy Segmentation
The South & Central America stem cell therapy is segmented into type, treatment, application, end user, and country.
Based on type, the South & Central America stem cell therapy is segmented into adult stem cell therapy, embryonic stem cell therapy, induced pluripotent stem cell therapy, and other stem cell therapy. In 2022, the adult stem cell therapy segment registered the largest share in the South & Central America stem cell therapy. The adult stem cell therapy segments is further segmented into hematopoietic stem cell therapy, umbilical cord stem cell therapy, neuronal stem cell therapy, and mesenchymal stem cell.
Based on treatment, the South & Central America stem cell therapy is bifurcated into allogeneic and autologous. In 2022, the allogeneic segment registered a larger share in the South & Central America stem cell therapy.
Based on application, the South & Central America stem cell therapy is segmented into musculoskeletal, dermatology, cardiology, drug discovery & development, and other applications. In 2022, the musculoskeletal segment registered the largest share in the South & Central America stem cell therapy.
Based on end user, the South & Central America stem cell therapy is bifurcated into hospitals & specialty clinics and academic & research institutes. In 2022, the academic & research institutes segment registered a larger share in the South & Central America stem cell therapy.
Based on country, the South & Central America stem cell therapy is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil segment registered the largest share in the South & Central America stem cell therapy.
Lonza Group AG, Pluri Inc, Smith & Nephew Plc, and TiGenix NV (Takeda Pharmaceutical Company Limited) are some of the leading companies operating in the South & Central America stem cell therapy.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Stem Cell Therapy Market - By Type
1.3.2 South & Central America Stem Cell Therapy Market - By Treatment
1.3.3 South & Central America Stem Cell Therapy Market - By Application
1.3.4 South & Central America Stem Cell Therapy Market - By End User
1.3.5 South & Central America Stem Cell Therapy Market - By Country
2. South & Central America Stem Cell Therapy Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Stem Cell Therapy Market- Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Experts Opinion
5. South & Central America Stem Cell Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. Stem Cell Therapy Market - South & Central America Analysis
6.1 South & Central America Stem Cell Therapy Market Revenue Forecast and Analysis
7. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - by Type
7.1 Overview
7.2 South & Central America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Treatment
8.1 Overview
8.2 South & Central America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Application
9.1 Overview
9.2 South & Central America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - by End User
10.1 Overview
10.2 South & Central America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 - Country Analysis
11.1 Overview
11.1.1 South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028(%)
11.1.1.1 Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.1.2 Brazil: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.1.1.1.2.1 Brazil: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.1.1.1.3 Brazil: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.1.1.1.4 Brazil: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.1.1.1.5 Brazil: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.1.1.2 Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.2.2 Argentina: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.1.1.2.2.1 Argentina: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.1.1.2.3 Argentina: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.1.1.2.4 Argentina: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.1.1.2.5 Argentina: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.1.1.3 Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.3.2 Rest of South and Central America: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.1.1.3.2.1 Rest of South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.1.1.3.3 Rest of South and Central America: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.1.1.3.4 Rest of South and Central America: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.1.1.3.5 Rest of South and Central America: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
12. South & Central America Stem Cell Therapy Market-Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 TiGenix NV (Takeda Pharmaceutical Company Limited)
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 NuVasive Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza Group AG
13.3.1 Business Description
13.3.2 Products and Services
13.3.3 Financial Overview
13.3.4 SWOT Analysis
13.3.5 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South and Central America Stem Cell Therapy Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy - Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of South and Central America Stem Cell Therapy Market, by Treatment - Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of South and Central America Stem Cell Therapy Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South and Central America Stem Cell Therapy Market, by End-User - Revenue and Forecast to 2028 (USD Million)
Table 16. Organic Developments in the South & Central America stem cell therapy market
Table 17. Inorganic Developments in the South & Central America stem cell therapy market
Table 18. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America Stem Cell Therapy Market Segmentation
Figure 2. South & Central America Stem Cell Therapy Segmentation, By Country
Figure 3. South & Central America Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in South & Central America Stem Cell Therapy Market
Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South & Central America (SCAM) PEST Analysis
Figure 7. Experts Opinion
Figure 8. South & Central America Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Stem Cell Therapy Market - Revenue Forecast and Analysis - 2020- 2028
Figure 10. South & Central America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Adult Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Hematopoietic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Umbilical Cord Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Neuronal Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Mesenchymal Stem Cell: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Embryonic Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Induced Pluripotent Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Other Stem Cell Therapy: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. South & Central America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 20. Allogeneic: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Autologous: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. South & Central America Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 23. Musculoskeletal: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Dermatology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Cardiology: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Drug Discovery and Development: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Academic & Research Institutes: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Hospitals & Specialty Clinics: South & Central America Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. South and Central America Stem Cell Therapy Market, by Key Country - Revenue (2021) (USD Million)
Figure 32. South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 33. Brazil: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Argentina: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Rest of South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security